Schedule 13D ownership disclosure

LIPELLA PHARMACEUTICALS INC

Security class unavailable · CUSIP: 53630L100

Event date: 2022-12-19

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
18.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001753926-22-001652
Form type
SC 13D
Filer
Kaufman Jonathan H
CIK
CIK 1959250
Filed
Dec 29, 2022
Reporting period
Dec 19, 2022
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub